The therapeutic application of Hydrocortisone is generally defined by its role in providing essential support for hormone replacement and as a key agent in managing inflammation, contributing to symptomatic relief across distinct clinical domains. The medication is used across domains where additional symptomatic support is needed due to underlying deficiency or heightened physiological activity.

It is commonly used to help with conditions characterized by periods of heightened symptoms, including adrenocortical insufficiency, severe rheumatoid disorders, inflammatory diseases like ulcerative colitis, and intense inflammatory skin conditions. This makes it relevant for easing the overall symptomatic burden in situations involving chronic systemic imbalance or acute inflammatory or irritative processes.

“This medication helps manage distressing manifestations such as persistent itching and profound weakness, offering symptomatic relief that helps patients cope more steadily.”

This support assists with maintaining functional stability and may assist with the acute management of flare-ups.

Quick Fact: Relief for Inflammation
Hydrocortisone is applied in addressing symptom clusters that may become intense or disruptive, providing supportive relief when symptoms create noticeable physiological strain.

Official Eligibility and Contraindications

Hydrocortison acis (Hydrocortisone) eligibility is strictly defined by government regulatory documents, focusing on patient status, age, and pre-existing conditions.

Category	Eligibility Rule (Regulatory Basis)
Contraindicated Populations	Systemic fungal infections and known hypersensitivity to the medicine or its components [FDA, SmPC]. Also prohibited for patients who have received a live vaccine while taking immunosuppressive doses [FDA, SmPC].
Use Allowed	Approved for use in adults and children for hormone replacement therapy, including Adrenocortical Insufficiency and Congenital Adrenal Hyperplasia [FDA, EMA].
Age-Related Restrictions	Prolonged use in children and infants is restricted by the requirement for careful monitoring of growth and development [FDA]. Specific oral forms have safety/efficacy not established in children younger than five years [Mayo Clinic].
Condition-Specific Cautions	Use requires caution in patients with pre-existing conditions such as diabetes mellitus, hypertension, renal insufficiency, liver failure (cirrhosis), and certain gastrointestinal issues like peptic ulcers [FDA, SmPC].
Pregnancy and Lactation	Use during pregnancy is restricted, requiring the benefits to be weighed against potential hazards to the fetus. The drug is excreted in breast milk, though replacement doses are generally not expected to cause a clinically significant impact on the nursing child [EMA, FDA].

These official regulatory statements define the populations who must not use the medicine and those who require careful monitoring due to the drug's systemic effects on the immune and metabolic systems.

Interactions with Other Medicines and Products

Hydrocortisone (the active substance in Hydrocortison acis) interacts with several medication classes, primarily by altering its concentration in the body or by increasing the risk of specific side effects when used together.

Pharmacokinetic (Concentration) Interactions

The concentration of hydrocortisone can be significantly altered by medicines that affect the CYP3A4 enzyme system in the liver. Inducers (e.g., Rifampin, Phenytoin, Carbamazepine, Barbiturates) may decrease hydrocortisone levels, potentially reducing its effectiveness. Conversely, strong inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin) may increase hydrocortisone levels, potentially leading to increased steroid effects.

Pharmacodynamic (Risk) Interactions

This class of interactions results in an additive risk of adverse effects, not a change in drug level:

Interacting Product Category	Documented Risk Increase
Potassium-Depleting Agents (e.g., Diuretics)	Increased risk of hypokalemia (low potassium).
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)	Increased risk of gastrointestinal ulceration or bleeding.
Antidiabetic Agents	Hydrocortisone may raise blood glucose; adjustment of antidiabetic agents may be required.

Contraindications and Special Warnings

Use of hydrocortisone in immunosuppressive doses is restricted with live or live, attenuated vaccines. The use of Mifepristone is restricted due to the potential for severe adverse reactions. The effect of hydrocortisone may be enhanced in patients with hypothyroidism or cirrhosis.

How Hydrocortisone Acetate Works

Hydrocortisone acetate is a glucocorticoid that modulates fundamental processes of the body's inflammatory and immune systems by acting as an agonist for cytoplasmic glucocorticoid receptors. This drug-receptor complex translocates into the cell nucleus, where it alters gene expression.

This genomic action leads to transactivation, increasing the production of anti-inflammatory proteins, and transrepression, suppressing the synthesis of pro-inflammatory mediators. A key consequence is the induction of proteins that inhibit the enzyme phospholipase A2. This inhibition blocks the release of arachidonic acid, thereby preventing the formation of subsequent inflammatory molecules like prostaglandins and leukotrienes.

Further physiological modulation occurs as the drug reduces the number and activity of certain immune cells in affected areas. Concurrently, it helps stabilize the membranes of blood vessels (capillaries), which limits the migration of immune cells and prevents the leakage of fluid into the tissue, resulting in changes to cellular and system activity.

Official Administration Guidelines

Hydrocortisone, the active substance in Hydrocortison acis, is administered through several officially approved routes, including oral forms (immediate-release or modified-release tablets) and parenteral forms (intravenous or intramuscular injection), with the route determined by the necessary speed of action and clinical context.

For chronic hormone replacement, the total daily dose for adults typically ranges from 15 mg to 25 mg, which is usually administered as divided doses to approximate the body's natural release of cortisol. The largest portion of this dose is commonly scheduled in the morning to align with the body's diurnal rhythm. Immediate-release oral forms may be taken with or after food, while specific modified-release tablet formulations must be swallowed whole and taken at least 30 minutes before food.

Acute Use and Procedural Requirements

In acute or emergency settings, the parenteral route is preferred, utilizing a sterile powder that must be reconstituted prior to injection. Initial doses for acute management commonly range from 100 mg to 500 mg (IV or IM) and may be repeated every two, four, or six hours as needed. This high-dose therapy is typically limited to a short duration, often 48 to 72 hours.

The practice of stress dosing involves temporarily increasing the daily maintenance amount during periods of significant physical stress, such as severe illness or major surgery. Furthermore, following prolonged systemic use, the medicine must always be gradually withdrawn (tapered) rather than stopped abruptly.

Research evidence / Overview of Studies for Hydrocortison acis

Evidence for Hydrocortisone as Hormone Replacement Therapy

Research examined hydrocortisone in the context of Adrenocortical Insufficiency (AI), exploring outcomes related to functional imbalance. Studies, including short-term Randomized Controlled Trials (RCTs), compared standard hydrocortisone tablets with newer modified-release formulations. Researchers monitored physiological markers (cortisol concentration curves) and metabolic endpoints (BMI, blood sugar control). The findings describe patterns comparing the extent to which different formulations matched the body's natural hormone cycle. The use for replacement is well-established for use in this condition, though comparative data are often based on short follow-up durations (frequently three months). Long-term effects are not fully established.

Evidence for Hydrocortisone in Managing Inflammation and Immune Responses

Research examined hydrocortisone in studies focusing on active, severe flares of Ulcerative Colitis (UC). Clinical trials explored short-term outcomes linked to inflammatory states, monitoring specific clinical measures and symptom patterns. Findings describe patterns related to measured symptoms and the rate of achieving clinical response. While research provides insight into short-term results, evidence is limited regarding optimal long-term management. The outcome of corticosteroid dependency was associated with this treatment in some studies, and comparative evidence against some newer therapies is lacking.

Evidence for Hydrocortisone in Acute Stress and Crisis Management

Hydrocortisone was also evaluated in settings of severe physiological strain (such as sepsis or major surgery) in patients with Adrenal Insufficiency. Research, including Pharmacokinetic/Pharmacodynamic (PK/PD) studies and RCTs, examined outcomes related to vital function stabilization. Studies monitored measures like cardiovascular performance and the need for support medications. Research provides context for how the body utilizes cortisol during periods of acute stress. Placebo-controlled comparative evidence for life-threatening scenarios is lacking, and optimal dosing remains an area of study.

Research on Follow-Up Duration and Long-Term Outcomes

Studies exploring outcomes for chronic conditions have often had follow-up durations that were limited to short or intermediate timeframes. Research so far indicates that while short-term outcomes were measured, there is limited information for long-term outcomes and the durability of response to treatment, particularly concerning the impact on health markers over many years.

Evidence Studies in Specific Patient Populations

Evidence was evaluated in studies for specific groups. Research has explored the use of hydrocortisone for managing active ulcerative colitis flares in children and in adults with AI who also manage co-existing conditions, such as diabetes. For many other groups, subgroup findings are uncertain, and data remain insufficient.

Uncertainties and Gaps in the Research Evidence

Key limitations include sample sizes that were modest in some comparative trials, meaning results apply only to the populations studied. Furthermore, many studies are limited to comparing different formulations or doses rather than comparing treatment to no treatment.

Key Studies & References

1. Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency (Clinical Trial NCT00915343)
2. The Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) Trial (Review discussing major sepsis RCTs)

Common questions about Hydrocortison acis (FAQ)

Q: Is Hydrocortison acis the same type of medicine as Hydrocortisone cream?

A: Hydrocortison acis is a name for a medicine whose active substance is hydrocortisone, which is chemically identical to the body's natural cortisol. This active substance is made available in different physical forms, such as oral tablets and topical creams or ointments. According to official documents, the different dosage forms use the same core substance but contain different inactive ingredients to suit their intended use (systemic versus local).

Q: Can Hydrocortison acis be taken with pain relievers like ibuprofen?

A: Regulatory documents indicate that using hydrocortisone with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may increase the potential risk of stomach-related side effects. Specifically, the official product information describes an increased risk of complications like gastrointestinal bleeding or ulceration when these types of medicines are used together.

Q: Can a person stop taking Hydrocortison acis suddenly?

A: Regulatory guidelines indicate that stopping abruptly is restricted after prolonged systemic use. The medicine must always be gradually withdrawn (tapered) under clinical guidance. This practice is necessary to help the body's own adrenal glands recover their function, as abrupt discontinuation carries the risk of inducing severe adrenocortical insufficiency.

Q: What is the general duration of treatment with Hydrocortison acis?

A: The required duration of treatment depends entirely on the condition being addressed. Official documentation describes its use for chronic hormone replacement, which involves long-term administration. Conversely, for very acute or emergency management, high-dose therapy is typically limited to a short duration, such as 48 to 72 hours.

Q: Does taking Hydrocortison acis make me gain weight?

A: Official documents list increased appetite and weight gain as potential adverse reactions associated with the use of systemic corticosteroids. The occurrence of these effects is often associated with the dose and duration of treatment.

Q: Does Hydrocortison acis affect sleep or energy levels?

A: Official product information states that sleep disturbances, such as insomnia, are documented as common adverse reactions. Furthermore, symptoms like fatigue or low energy levels may be noted in official information, particularly during the withdrawal phase related to potential adrenal insufficiency.

Q: Can Hydrocortison acis cause changes in mood or anxiety?

A: Official documents list behavioral and mood changes as potential adverse reactions that are common. These may include anxiety, euphoria, mood swings, personality changes, and in rare cases, more severe depression or psychotic reactions. These are classified under psychiatric disorders in the official labeling.

Q: Is Hydrocortison acis suitable for children or adolescents?

A: Official documents describe the use of hydrocortisone in the pediatric population for various conditions. A known risk described in regulatory information is growth retardation in children. For this reason, official information emphasizes the need for careful monitoring of growth and development during pediatric use.

Q: Are there specific vitamins or supplements that interact with Hydrocortison acis?

A: Regulatory guidance often advises that the safety of taking general herbal remedies and supplements with hydrocortisone has not been formally established in the same way as prescription medicines. Some sources, for instance, indicate that certain foods like grapefruit juice may increase the level of hydrocortisone in the body.

Q: Is Hydrocortison acis known to affect blood sugar levels?

A: Yes, official documents indicate that hydrocortisone can affect glucose metabolism. Possible adverse effects include hyperglycemia (high blood sugar) and a decrease in how the body handles carbohydrates. This effect is why the medicine may modify the requirement for antidiabetic medicines in people with pre-existing diabetes.

Q: What happens in the body when Hydrocortison acis is working?

A: Hydrocortisone is classified as a glucocorticoid, a substance that acts on specific receptors inside cells to change how they function. This core action is described as resulting in a powerful anti-inflammatory effect and modification of the immune system. This cellular process is the foundation for its therapeutic uses.

Q: Are there any long-term effects of taking Hydrocortison acis as described in official documents?

A: Yes, long-term use is associated with several effects described in regulatory documents. These include the risk of developing Cushingoid features, osteoporosis (thinning of bones), cataracts, and suppression of the adrenal gland function (HPA axis).

Q: Is Hydrocortison acis often prescribed for allergic reactions?

A: Official regulatory documents list the control of severe or incapacitating allergic conditions as an approved use for hydrocortisone. This use is generally reserved for allergic states that have not responded adequately to standard conventional treatments.

Q: Can Hydrocortison acis be taken by someone with a stomach ulcer history?

A: Regulatory documents state that caution is required when using hydrocortisone in patients who have a history of peptic ulceration or other serious gastrointestinal disorders. This is because there is an increased risk of complications such as perforation and hemorrhage.

Q: Why is Hydrocortison acis sometimes given in combination with other drugs?

A: Hydrocortisone is sometimes given in combination with other drugs for hormone replacement therapy. Specifically, in cases of primary adrenocortical insufficiency, it may be combined with mineralocorticoids to ensure both components of the hormone deficiency are addressed, as described in official indications.

Q: Is Hydrocortison acis safe to use for people with high blood pressure?

A: Regulatory documents state that caution is required when using hydrocortisone in patients with pre-existing hypertension (high blood pressure). The medicine itself can potentially cause or worsen fluid retention and elevate blood pressure, as noted in official warnings.

Q: Are there differences in how Hydrocortison acis works depending on the condition being treated?

A: The official mechanism of action describes one core process: hydrocortisone acts as a glucocorticoid receptor agonist to achieve an anti-inflammatory and immune-system-modifying effect. This core action serves as the foundation for its therapeutic benefit across all approved conditions.

Q: Does official information mention any specific lab tests that are affected by Hydrocortison acis?

A: Official information indicates that the medicine may affect certain lab values, such as leading to changes in blood sugar and potassium levels. It is also noted that corticosteroids may suppress the reactions seen in skin tests.

Q: Is it important to take Hydrocortison acis with food?

A: Official guidelines describe that immediate-release oral forms of hydrocortisone may be taken with or after food. However, specific modified-release forms are instructed to be taken at least 30 minutes before food. The specific timing instructions provided in the official labeling vary based on the formulation being used.

Q: Are there any reported interactions between Hydrocortison acis and common herbal remedies?

A: Regulatory guidance often states that there is not enough information to confirm the safety of using hydrocortisone with many herbal remedies and supplements. These products are not routinely evaluated for their potential to interact with prescription medicines.

Q: Does Hydrocortison acis impact fertility or planning a pregnancy?

A: Official documents advise that the medicine should be used during pregnancy only if the potential benefit is determined to justify the potential risk to the fetus. Consideration of benefits versus possible hazards is a standard evaluation outlined in the official documentation for use during pregnancy.

Q: What are the general guidelines for using Hydrocortison acis in older adults?

A: Official documents advise that, when determining the dose for an older adult, general caution is used. This is often due to the increased frequency of reduced organ function, and the potential presence of other medical conditions or drug therapies in this population.

Q: Does Hydrocortison acis cause fluid retention?

A: Yes, official documents list the possibility of fluid retention and sodium retention as documented adverse reactions associated with the use of hydrocortisone.

Q: Does Hydrocortison acis affect eye health or vision?

A: Official documents list potential adverse effects on the eyes, particularly with prolonged use. These effects include the possibility of developing posterior subcapsular cataracts and glaucoma (increased pressure inside the eye).

Q: Can Hydrocortison acis interact with oral contraceptives?

A: Official documents state that estrogens, which are found in oral contraceptives, may potentially enhance the effects of hydrocortisone. This is due to a decrease in the rate at which hydrocortisone is processed and cleared from the body, which may necessitate a dose adjustment, as noted in the official documentation.

How to Store and Dispose of Hydrocortison acis

The official storage conditions for Hydrocortison acis 10 mg tablets are strictly defined to maintain product stability and safety.

Storage Requirements

Condition	Requirement (Official Labeling)
Temperature Constraint	Store at a temperature not exceeding 30 °C (not over 86 °F).
Container & Protection	Keep the medicine in the original packaging to protect from light and moisture.
Child Safety	Must be kept out of the sight and reach of children.

Disposal Instructions

Official regulatory guidelines prohibit disposal of expired or unused Hydrocortison acis tablets via wastewater (e.g., flushing) or household waste. Individuals are instructed to consult their pharmacist for the correct procedure on how to discard the medicine, ensuring disposal complies with local environmental requirements.